Skip to main content

Cogentin News

FDA Medwatch Alert: Benztropine Mesylate Injection (Nexus Pharmaceuticals): Recall - Visible Particulate Matter

ISSUE: Nexus Pharmaceuticals Inc. is recalling two lots of Benztropine Mesylate Injection, USP, 2 mg/2mL (1mg/mL) in 2 mL single dose vials due to the presence of visible particulate matter in the...

FDA Medwatch Alert: Benztropine Mesylate Injection by Fresenius Kabi USA: Recall - Potential Presence Of Glass Particles

ISSUE: Fresenius Kabi USA is voluntarily recalling four lots of Benztropine Mesylate Injection, USP, 2 mg/2mL (1mg/mL) in 2 mL single dose vials due to the potential presence of glass particles...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Extrapyramidal Reaction, Parkinson's Disease

Cogentin patient information at Drugs.com